By: Liza Tobin & Addis Goldman (Project Syndicate)
In the aftermath of the Great Recession of 2008-09, there was widespread belief that China’s economy would surpass that of the United States by 2030. However, China is now grappling with various crises that threaten its economic “miracle.” To regain momentum and bolster its strategic position, China is shifting its focus from real estate to advanced industries as the primary growth engine. The US response will play a crucial role in determining the outcome of the strategic competition between the two nations and the future of the global economy.
The US economy remains vibrant, as evidenced by its swift recovery from the COVID-19 shock. A key factor behind this resilience is US leadership in artificial intelligence, which is already generating economic value across various industries and holds potential for significant productivity gains. With substantial investments in cloud infrastructure by US technology companies, the American innovation ecosystem is poised to benefit from enterprise-scale AI capabilities. As 2030 nears, these advancements could drive innovation in “deep-tech” sectors such as robotics and biotechnology.
Despite its strengths, the US economy has a significant shortfall: insufficient production capacity in advanced industries like semiconductors and clean energy, which are vital for economic competitiveness and national security. Since 1980, the US share of global high-tech goods manufacturing has plummeted from over 40% to just 18%.
While the US has experienced deindustrialization, China has risen as the world’s manufacturing superpower, transitioning from dominance in textiles and toys to leadership in advanced technologies like networking components, electrical equipment, and machine tools. China now produces more than half of the world’s electric vehicles and is projected to control over 80% of global solar-cell manufacturing capacity through 2026…
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI